These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25542696)

  • 1. Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients.
    Peric KM; Reeves DJ
    Leuk Res; 2015 Feb; 39(2):173-6. PubMed ID: 25542696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
    Wenzell CM; Gallagher EM; Earl M; Yeh JY; Kusick KN; Advani AS; Kalaycio ME; Mukherjee S; Tiu RV; Maciejewski JP; Sekeres MA
    Am J Hematol; 2013 Oct; 88(10):906-9. PubMed ID: 23828018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.
    Hansen J; Stephan JM; Freesmeier M; Bender D; Button A; Goodheart MJ
    Gynecol Oncol; 2015 Jul; 138(1):154-8. PubMed ID: 25958318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J; Toste B; Dizon DS
    Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in obese patients undergoing induction therapy for acute leukemia.
    Dombrowski L; Mohassel L
    J Oncol Pharm Pract; 2019 Jul; 25(5):1058-1065. PubMed ID: 29726788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of acute myeloid leukemia in an obese patient--determining the therapeutic dose of anticancer drugs].
    Kawaguchi Y; Inagaki A; Sato Y; Ogura H; Wakita A
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2603-5. PubMed ID: 25596056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia.
    Trepte ML; Auten JJ; Clark SM; van Deventer HW
    J Oncol Pharm Pract; 2019 Jun; 25(4):801-805. PubMed ID: 29475404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
    Goto T; Tanimoto K; Ishibashi M; Okamura S
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1227-32. PubMed ID: 22902447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia.
    Kempf E; Hirsch P; Labopin M; Viguié F; Isnard F; Tang R; Marzac C; Marie JP; Mohty M; Legrand O
    Leuk Res; 2014 Dec; 38(12):1425-9. PubMed ID: 25443887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early implementation of antifungal therapy in the management of febrile neutropenia is associated with favourable outcome during induction chemotherapy for acute leukaemias.
    Khalafallah A; Maiwald M; Hannan T; Abell S; Staker J; Supperamohan A
    Intern Med J; 2012 Feb; 42(2):131-6. PubMed ID: 22151972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit.
    Ng WL; Della-Fiorentina SA
    Eur J Cancer Care (Engl); 2010 May; 19(3):403-7. PubMed ID: 19686353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
    Bradley AM; Deal AM; Buie LW; van Deventer H
    Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary infiltrates in acute myeloid leukemia during induction treatment: how much do we know?
    Muslimani A; Chisti MM; Margolis J; Nadeau L; Ye H; Micale M; Huang J; Jaiyesimi I
    Am J Clin Oncol; 2014 Aug; 37(4):377-83. PubMed ID: 23357975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.
    Yilmaz S; Oren H; Demircioğlu F; Irken G
    Pediatr Hematol Oncol; 2008; 25(3):195-204. PubMed ID: 18432502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.
    López-Jiménez J; Martín-Ballesteros E; Sureda A; Uralburu C; Lorenzo I; del Campo R; Fernández C; Calbacho M; García-Belmonte D; Fernández G
    Haematologica; 2006 Jan; 91(1):84-91. PubMed ID: 16434375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of combination with granisetron and methylprednisolone for nausea, vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia--a randomized comparative trial between granisetron alone and granisetron plus methylprednisolone].
    Ono K; Uchida I; Uno N; Ohno E; Hirota K; Nakayama T; Ohtuka E; Saburi Y; Kikuchi H; Nasu M
    Gan To Kagaku Ryoho; 1999 May; 26(6):821-8. PubMed ID: 10410152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.